C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 413/04 (2006.01) A61K 31/4245 (2006.01) A61K 31/454 (2006.01) A61K 31/4545 (2006.01) A61K 31/497 (2006.01) C07D 413/14 (2006.01) C07D 471/08 (2006.01) C07D 487/08 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2743536
The present application relates to novel aryl compounds with heterocyclic substituents, processes for their preparation, their use for treatment and/or prevention of diseases and their use for the preparation of medicaments for treatment and/or prevention of diseases, in particular for treatment and/or prevention of hyperproliferative and angiogenic diseases and those diseases which arise from metabolic adaptation to hypoxic states. Such treatments can be carried out as monotherapy or also in combination with other medicaments or further therapeutic measures.
La présente invention concerne de nouveaux composés aryles substitués par hétérocycle, un procédé permettant de les préparer, leur utilisation pour le traitement et/ou la prévention de maladies ainsi que leur utilisation pour la fabrication de médicaments pour le traitement et/ou la prévention de maladies, en particulier pour le traitement et/ou la prévention de maladies hyperprolifératives et angiogèniques, ainsi que des maladies qui se produisent par une adaptation métabolique à des états hypoxiques. De tels traitements peuvent avoir lieu en tant que monothérapie ou également en combinaison avec d'autres médicaments ou autres mesures thérapeutiques.
Beck Hartmut
Berhoerster Kerstin
Ellinghaus Peter
Greschat Susanne
Haerter Michael
Bayer Schering Pharma Aktiengesellschaft
Fetherstonhaugh & Co.
LandOfFree
Heterocyclically substituted aryl compounds as hif inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclically substituted aryl compounds as hif inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclically substituted aryl compounds as hif inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1925496